Gelofusine

Known as: Gelofusines 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
OBJECTIVE To study the changes in blood volume and hormones controlling sodium and water homeostasis after infusions of 0.9… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
UNLABELLED Strong overexpression of glucagonlike peptide-1 (GLP-1) receptors in human insulinoma provides an attractive target… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2009
2009
Peptide receptor radionuclide therapy using β-emitting radiolabelled somatostatin analogues like DOTA,Tyr3-octreotate shows… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
AIM In peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues, kidney uptake of radiolabelled… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
UNLABELLED Nephrotoxicity due to renal reabsorption of radiolabeled peptides limits the tumor dose in peptide receptor… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
OBJECTIVES Previous studies have shown that in children with severe malaria, resuscitation with albumin infusion results in a… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2006
2006
The plasma expander Gelofusine (succinylated gelatin) is a recognised cause of peri-operative anaphylaxis. Current diagnosis of… (More)
Is this relevant?
2005
2005
OBJECTIVE To investigate the effect of HES, used as a plasma volume expander, on endothelial cell activation induced by ischaemia… (More)
Is this relevant?
2002
2002
A case of anaphylactoid reaction due solely to the use of Gelofusine in a patient with non-haemorrhagic hypovolaemia is presented… (More)
Is this relevant?
2001
2001
PURPOSE Proteinuria is frequently encountered in patients in the intensive care unit, most likely as a result of renal tubular… (More)
Is this relevant?